Products for Research Use Only
RegisterLogin

Cudarolimab

CAT: 0804-HY-P99836-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99836-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Cudarolimab (IBI101) is a completely human anti-OX40 (CD134, a co stimulating molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has antitumor activity and can be used in cancer related research[1].
CAS Number
2244739-29-3
Product Name Alternative
IBI101
UNSPSC
12352203
Target
Orexin Receptor (OX Receptor)
Type
Inhibitory Antibodies
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cudarolimab.html
Purity
95.00
Solubility
10 mM in DMSO
Smiles
[Cudarolimab]
Molecular Weight
(145.94 kDa)
References & Citations
[1]Kuang Z, et al. Development and characterization of a novel anti-OX40 antibody for potent immune activation. Cancer Immunol Immunother. 2020 Jun;69 (6) :939-950.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1

Alternative Products

CatalogName
591773Cudarolimab
GTR18338335-01Cudarolimab Antibody
HW342046-01Research Grade Cudarolimab
E55B0386Cudarolimab (Reference antibody)
21-896Cudarolimab - Research Grade Biosimilar
ICH5458-20mgCudarolimab Biosimilar - Research Grade
GTR18780510-01(Cudarolimab) Biosimilar Reference Antibody
GTR18697837-01Cudarolimab Human Monoclonal Antibody
C00575-1mg*25Cudarolimab (Anti-TNFRSF4 / OX40 / CD134)
047841TNFRSF4/OX40/CD134 (cudarolimab) discontinued

Popular Products